Quotables
"I hate what they've done to my child...I would never let my own children watch it. "
Vladimir Zworykin, television pioneer ; Talking about an invention in which he played a critical role.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7087223 | Preventives and/or remedies for hyperphosphatemia Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect... | 08/08/2006 |
| 6268368 | Anionic exchange polymer complexes of buspirone A controlled release form of buspirone medicament is described. This medicament comprises a buspirone in intimate admixture with an anionic exchange polymer complexing agent. These components form a complex upon the addition of water and thereby permit im... | 07/31/2001 |
| 6007803 | Ionic polymers as toxin binding agents A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c... | 12/28/1999 |
| 5888526 | Antibacterial antifungal agent and fibrous material containing the same The present invention is to provide a fibrous material containing an antibacterial antifungal agent consisting of specific metal salt of organic compound effective for both antibacterial and antifungal functions and various articles containing the same fi... | 03/30/1999 |
| 5591721 | Method of down-regulating gene expression Disclosed is a method of down-regulating the expression of a gene in an animal, wherein a pharmalogical formulation comprising an oligonucleotide complementary to the gene is orally administered to an animal. The oligonucleotide administered has non-phosp... | 01/07/1997 |
| 5575993 | Ionene polymers containing biologically-active anions Ionene polymers having biologically-active organic and/or inorganic anions are described. Methods to prepare the ionene polymers, compositions containing them and their methods of use are also described.... | 11/19/1996 |
| 5413782 | Binding pharmaceuticals to ion exchange resins In a method in which an ionizable pharmaceutical material, such as theophylline, having a pharmaceutically-active anionic group is bonded to an anion exchange resin having cationic groups bonded to displacable anionic groups by bringing said material and ... | 05/09/1995 |
| 5162110 | Binding theophylline to ion exchange resins In a method in which an ionizable pharmaceutical material, such as theophylline, having a pharmaceutically-active anionic group is bonded to an anion exchange resin having cationic groups bonded to displacable anionic groups by bringing said material and ... | 11/10/1992 |
| 5152986 | Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives Known antibacterial quinolonecarboxylic acid derivatives such as ciprofloxacin are administered to animals in their food in the form of weak cation exchangers loaded therewith. The taste is much improved and the animals accept the material more readily.... | 10/06/1992 |
| 4996047 | Sustained release drug-resin complexes Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subseq... | 02/26/1991 |
| 4929440 | Process for the preparation of (-) eburnamenin-14-(15H)-one resinates A process for the preparation of (-)eburnamenin-14-(15H)-one resinates having improved pharmacological properties. These resinates are prepared by reacting phosphate or any addition salts of (-)eburnamenin-14-(15H)-one with an alkali metal sulphonate type cati... | 05/29/1990 |
| 4772463 | Macromolecular CDP-choline derivatives, process for their preparation and pharmaceutical compositions containing them CDP-choline derivatives with macromolecules containing carboxy groups, such as polyacrylates, polymethacrylates, polyglutamates, polyaspartates and polymaleates, or copolymers of acrylic acid and methacrylic acid with methyl acrylate, methyl methacrylate ... | 09/20/1988 |
| 4578268 | Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals There are provided palatable anthelmintic resinate compositions for companion animals, containing anthelmintically effective amounts of a styrylpyridinium compound and/or an N,N-dialkylpiperazine carboxamide.... | 03/25/1986 |
| 4369175 | Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them The invention relates to a process for the manufacture of prolonged action and stable vincamine preparations, which process comprises reacting an acid addition salt of vincamine with an alkali metal salt or alkaline earth metal salt of a sulfonic acid cat... | 01/18/1983 |
| 4364928 | Novel salts of ion exchange resins of the acid type Ion exchange resins of the acid type at least partially salified with 7-bromo-6-chloro-febrifugin having very good coccidiostatic activity, a very good anti-leucocytozoonosis activity and a low toxicity and their preparation.... | 12/21/1982 |
| 4046898 | 6-Aryl-pyrrolo[1,2-a]Imidazole derivatives which possess anti-hypertensive activity 6-Aryl-pyrrolo[1,2-a]imidazole derivatives, processes for their manufacture, pharmaceutical compositions containing them and a method of using them to lower blood pressure in warm-blooded animals. Representative of the compounds disclosed is 6-(2,6-d... | 09/06/1977 |
